MedPath
NMPA Approval

Eprosartan Tablets

国药准字HJ20171293

January 13, 2021

H20171293

Drug Information

依普沙坦片

泰络欣

片剂

600mg

化学药品

January 13, 2021

January 12, 2026

Company Information

Applicant Company

C.J. van Houtenlaan 36 NL-1381 CP Weesp, the Netherlands

Manufacturing Company

Route de Belleville Lieu dit Maillard 01400 Chatillon Sur Chalaronne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依普沙坦片 - NMPA 批准文号 | MedPath